| Journal | Annals of medicine |
| Study Type | Clinical Study |
| Population | Human participants |
GPR3 represents an emerging therapeutic target that may explain interconnections between neurological, metabolic, immune, and reproductive disorders that cannabis medicine practitioners frequently encounter in complex patient presentations. Understanding this receptor’s multisystem influence could inform more targeted cannabinoid therapeutic approaches for patients with comorbid conditions.
This systematic review synthesizes evidence on GPR3, an orphan G-protein-coupled receptor with constitutive activity across brain, liver, ovary, and other tissues. The authors examined GPR3’s role in regulating cell proliferation, differentiation, and apoptosis across nervous, reproductive, immune, and metabolic systems through literature analysis from PubMed and Web of Science databases. Key findings highlight GPR3’s involvement in neuronal survival, synaptic plasticity, microglial function, immune inflammation, reproductive processes, and energy metabolism. The review identifies GPR3 as a potential therapeutic target for multisystem diseases, though specific clinical applications remain to be validated through controlled studies.
“While this receptor biology is fascinating, I remain focused on established endocannabinoid system targets where we have robust clinical evidence. GPR3 research may eventually inform cannabis medicine practice, but currently represents basic science rather than actionable clinical intelligence.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is GPR3 and why is it clinically significant?
GPR3 is an orphan G-protein-coupled receptor with constitutive Gs activity that regulates cell proliferation, differentiation, and apoptosis across multiple organ systems. It’s expressed in the brain, liver, ovary, and other tissues, making it a potential therapeutic target for neurodegenerative diseases, metabolic disorders, immune dysfunction, and reproductive health conditions.
How does GPR3 relate to neurological conditions?
GPR3 plays crucial roles in neuronal survival and synaptic plasticity, with involvement in neurodegenerative disease processes. The receptor’s activity in brain tissue suggests it may be a therapeutic target for conditions affecting cognitive function and neuronal health.
What role does GPR3 play in metabolic health?
GPR3 is involved in energy metabolism regulation through its expression in metabolically active tissues like the liver. Its signaling pathways may influence metabolic processes, making it relevant for understanding and potentially treating metabolic disorders.
How does GPR3 affect immune and inflammatory responses?
Research indicates GPR3 involvement in immune inflammation processes, suggesting it may modulate immune system function. This multisystem activity positions GPR3 as a potential target for inflammatory conditions that span multiple organ systems.
What are the current therapeutic implications of GPR3 research?
While GPR3 shows promise as a therapeutic target due to its multisystem involvement, current evidence remains at the early research stage. Further clinical studies are needed to establish specific therapeutic applications and develop targeted agonists or inhibitors for clinical use.
